Latest news
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Business WireBusiness Wire · Wed, 05 Aug 2026 12:00:00 GMTSilexion's SIL204 Alters Three Immune Pathways in Cancer Cells - Stock TitanStock Titan · Tue, 04 Aug 2026 13:15:00 GMTCognizin® Citicoline Shows Promise for Neuromuscular Health in New Preclinical Research - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMT